High-purity lithium serves as a reagent in sensitive pharmaceutical synthesis, eliminating trace contaminants for safety and consistency.

Pharmaceutical applications of lithium demand the highest purity standards. For decades, lithium carbonate (Li₂CO₃) has been used as an active pharmaceutical ingredient (API) in the treatment of bipolar disorder and depression, while lithium salts also serve as reagents in sensitive drug synthesis. In these contexts, even trace sodium, potassium, or heavy metals can cause unwanted side reactions or compromise patient safety.

This is where 99.99% (4N) lithium hydroxide (LiOH) plays a critical role. It provides the ultra-high-purity precursor required for pharma-grade carbonate and serves directly in the preparation of specialty reagents such as lithium alkoxides and lithium amides — essential building blocks in modern drug development.

Here, “battery-grade” is not acceptable. Pharma-grade lithium must consistently achieve 99.99% (4N) purity to ensure reproducibility, regulatory compliance, and patient safety.

As pharmaceutical research advances toward more complex molecules and precision therapies, the demand for ultra-high-purity lithium precursors will only expand. 4N LiOH and 4N Li₂CO₃ are not just reagents — they are foundations for innovation in medicine.

For more information on pharma-grade lithium applications, please contact